Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-linked Hypophosphatemic Rickets

Conditions

Hyperparathyroidism | Hypophosphatemia, Familial

What is the purpose of this trial?

The purpose of this study is to determine the effectiveness of paricalcitol, a form of synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease symptoms in children and adults with X-linked hypophosphatemic (XLH) rickets.


Participation Guidelines

Age:
9 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health
Yale University
Dates:
08/17/2006
Last Updated:
Study HIC#:
0607001636